Portal de Periódicos da CAPES

The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988–2003

2007; Wiley; Volume: 27; Issue: 6 Linguagem: Inglês

10.1002/pd.1741

1097-0223

Daniel L. Van Dyke, Salah Ebrahim, A. Al Saadi, Sherida Powell, Julie Zenger‐Hain, Mark A. Micale, Anne E. Wiktor, Ying Zou,

Prenatal Screening and Diagnostics

Prenatal DiagnosisVolume 27, Issue 6 p. 583-584 Correspondence The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988–2003 D. L. Van Dyke, Corresponding Author D. L. Van Dyke Henry Ford Health System, Detroit, MI, USA Mayo Clinic, Rochester, MN, USAHenry Ford Health System, Detroit, MI, USA.Search for more papers by this authorS. A. Ebrahim, S. A. Ebrahim Wayne State University, Detroit, MI, USASearch for more papers by this authorA. A. Al Saadi, A. A. Al Saadi William Beaumont Hospital, Royal Oak, MI, USA Esoterix Oncology, Brentwood TN, USASearch for more papers by this authorS. A. Powell, S. A. Powell St. John Hospital, Detroit, MI, USASearch for more papers by this authorJ. L. Zenger-Hain, J. L. Zenger-Hain Oakwood Hospital, Dearborn, MI, USASearch for more papers by this authorM. A. Micale, M. A. Micale William Beaumont Hospital, Royal Oak, MI, USASearch for more papers by this authorA. E. Wiktor, A. E. Wiktor Henry Ford Health System, Detroit, MI, USA Mayo Clinic, Rochester, MN, USASearch for more papers by this authorY. S. Zou, Y. S. Zou Mayo Clinic, Rochester, MN, USASearch for more papers by this author D. L. Van Dyke, Corresponding Author D. L. Van Dyke Henry Ford Health System, Detroit, MI, USA Mayo Clinic, Rochester, MN, USAHenry Ford Health System, Detroit, MI, USA.Search for more papers by this authorS. A. Ebrahim, S. A. Ebrahim Wayne State University, Detroit, MI, USASearch for more papers by this authorA. A. Al Saadi, A. A. Al Saadi William Beaumont Hospital, Royal Oak, MI, USA Esoterix Oncology, Brentwood TN, USASearch for more papers by this authorS. A. Powell, S. A. Powell St. John Hospital, Detroit, MI, USASearch for more papers by this authorJ. L. Zenger-Hain, J. L. Zenger-Hain Oakwood Hospital, Dearborn, MI, USASearch for more papers by this authorM. A. Micale, M. A. Micale William Beaumont Hospital, Royal Oak, MI, USASearch for more papers by this authorA. E. Wiktor, A. E. Wiktor Henry Ford Health System, Detroit, MI, USA Mayo Clinic, Rochester, MN, USASearch for more papers by this authorY. S. Zou, Y. S. Zou Mayo Clinic, Rochester, MN, USASearch for more papers by this author First published: 04 June 2007 https://doi.org/10.1002/pd.1741Citations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Haddow J, Palomaki GE, Knight GJ, et al. 1992. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 327: 588–593. Olsen C, Cross PK. 1997. Trends in the use of prenatal diagnosis in New York state and the impact of biochemical screening on the detection of Down syndrome: 1984–1993. Prenat Diagn 17: 1113–1124. Palomaki G, Beauregard L. 1996. Prenatal Screening for Down's Syndrome in Maine, 1980 to 1993. N Engl J Med 334: 1409–1410. Palomaki G, Knight GJ, McCarthy J, Haddow JE, Eckfeldt JH. 1993. Maternal serum screening for fetal Down Syndrome in the United States: a 1992 survey. Am J Obstet Gynecol 169: 1558–1562. Citing Literature Volume27, Issue6June 2007Pages 583-584 ReferencesRelatedInformation